Cargando…

Promoting population health with public-private partnerships: Where’s the evidence?

BACKGROUND: Although public-private partnerships have become common in the health sector, the evidence supporting their effectiveness is limited, and when the products or services provided by the private partner are harmful to health inherent conflicts of interest may be difficult to overcome. The o...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Lucy A., Zaragoza, Gustavo A., Hernández-Aguado, Ildefonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824113/
https://www.ncbi.nlm.nih.gov/pubmed/31675935
http://dx.doi.org/10.1186/s12889-019-7765-2
_version_ 1783464676001054720
author Parker, Lucy A.
Zaragoza, Gustavo A.
Hernández-Aguado, Ildefonso
author_facet Parker, Lucy A.
Zaragoza, Gustavo A.
Hernández-Aguado, Ildefonso
author_sort Parker, Lucy A.
collection PubMed
description BACKGROUND: Although public-private partnerships have become common in the health sector, the evidence supporting their effectiveness is limited, and when the products or services provided by the private partner are harmful to health inherent conflicts of interest may be difficult to overcome. The objective of this study is to appraise the evidence describing process or effectiveness of public-private partnerships (PPPs) that aim to promote population health, and analyse how characteristics such as independence or competing interests influence the results of their evaluation. METHODS: We carried out a systematic search of Medline and Web of Science to identify scientific reports evaluating the process or effectiveness of PPPs that aim to promote population health. Two reviewers applied inclusion criteria, extracted and evaluated study quality. We classified PPPs according to the health problem tackled, the independence of the evaluation, and the potential for competition between business interests of the private partner and health promotion activity undertaken. We classified the conclusions of the evaluation as positive (supportive/tentatively supportive) or negative (semi-critical/critical). RESULTS: We identified 36 studies evaluating 25 PPPs. Evaluations that were favourable to the use of PPPs in health promotion were more frequently classed as “not independent” and of poor quality. On the other hand, negative evaluations were more common when the PPP involved a private partner with a high potential for competition between the health promotion activity undertaken and their financial interests. PPPs that sought to prevent non-communicable diseases were more frequently negatively evaluated compared to PPPs tackling infectious disease or other types of health problem. Almost all of the evaluations evaluated process, with only 2 papers reporting quantitative health related outcomes. CONCLUSIONS: There is still a lack of sound evidence supporting the effectiveness of public-private partnerships in health promotion, and the evidence base is skewed by non-independent evaluations. Public health actors should abstain from engaging in agreements with industries whose business interests have a high potential for competition with the health promotion activity undertaken.
format Online
Article
Text
id pubmed-6824113
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68241132019-11-06 Promoting population health with public-private partnerships: Where’s the evidence? Parker, Lucy A. Zaragoza, Gustavo A. Hernández-Aguado, Ildefonso BMC Public Health Research Article BACKGROUND: Although public-private partnerships have become common in the health sector, the evidence supporting their effectiveness is limited, and when the products or services provided by the private partner are harmful to health inherent conflicts of interest may be difficult to overcome. The objective of this study is to appraise the evidence describing process or effectiveness of public-private partnerships (PPPs) that aim to promote population health, and analyse how characteristics such as independence or competing interests influence the results of their evaluation. METHODS: We carried out a systematic search of Medline and Web of Science to identify scientific reports evaluating the process or effectiveness of PPPs that aim to promote population health. Two reviewers applied inclusion criteria, extracted and evaluated study quality. We classified PPPs according to the health problem tackled, the independence of the evaluation, and the potential for competition between business interests of the private partner and health promotion activity undertaken. We classified the conclusions of the evaluation as positive (supportive/tentatively supportive) or negative (semi-critical/critical). RESULTS: We identified 36 studies evaluating 25 PPPs. Evaluations that were favourable to the use of PPPs in health promotion were more frequently classed as “not independent” and of poor quality. On the other hand, negative evaluations were more common when the PPP involved a private partner with a high potential for competition between the health promotion activity undertaken and their financial interests. PPPs that sought to prevent non-communicable diseases were more frequently negatively evaluated compared to PPPs tackling infectious disease or other types of health problem. Almost all of the evaluations evaluated process, with only 2 papers reporting quantitative health related outcomes. CONCLUSIONS: There is still a lack of sound evidence supporting the effectiveness of public-private partnerships in health promotion, and the evidence base is skewed by non-independent evaluations. Public health actors should abstain from engaging in agreements with industries whose business interests have a high potential for competition with the health promotion activity undertaken. BioMed Central 2019-11-01 /pmc/articles/PMC6824113/ /pubmed/31675935 http://dx.doi.org/10.1186/s12889-019-7765-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Parker, Lucy A.
Zaragoza, Gustavo A.
Hernández-Aguado, Ildefonso
Promoting population health with public-private partnerships: Where’s the evidence?
title Promoting population health with public-private partnerships: Where’s the evidence?
title_full Promoting population health with public-private partnerships: Where’s the evidence?
title_fullStr Promoting population health with public-private partnerships: Where’s the evidence?
title_full_unstemmed Promoting population health with public-private partnerships: Where’s the evidence?
title_short Promoting population health with public-private partnerships: Where’s the evidence?
title_sort promoting population health with public-private partnerships: where’s the evidence?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824113/
https://www.ncbi.nlm.nih.gov/pubmed/31675935
http://dx.doi.org/10.1186/s12889-019-7765-2
work_keys_str_mv AT parkerlucya promotingpopulationhealthwithpublicprivatepartnershipswherestheevidence
AT zaragozagustavoa promotingpopulationhealthwithpublicprivatepartnershipswherestheevidence
AT hernandezaguadoildefonso promotingpopulationhealthwithpublicprivatepartnershipswherestheevidence